(Q48768042)

English

Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolism

scientific article published on March 19, 1991

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/1712305

Injection of tachykinins and selective neurokinin receptor ligands into the substantia nigra reticulata increases striatal dopamine and 5-hydroxytryptamine metabolism (English)

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

tachykinin receptor

0 references

0 references

substantia nigra

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Christian Humpel

1

object named as

C. Humpel

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712305

5 November 2022

author name string

A. Saria

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712305

5 November 2022

D. Regoli

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1712305

5 November 2022

language of work or name

0 references

publication date

1 March 1991

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/1712305

19 March 1991

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1712305

5 November 2022

full work available at URL

https://api.elsevier.com/content/article/PII:0014299991903876?httpAccept=text/xml

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

https://api.elsevier.com/content/article/PII:0014299991903876?httpAccept=text/plain

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

European Journal of Pharmacology

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/1712305

195

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/1712305

107-114

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/1712305

1

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/1712305

Regional distribution of neuropeptide K and other tachykinins (neurokinin A, neurokinin B and substance P) in rat central nervous system.

1

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Substance P and neurokinin A regulate by different mechanisms dopamine release from dendrites and nerve terminals of the nigrostriatal dopaminergic neurons

2

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Substance P, neurotensin and enkephalin injections into the ventral tegmental area: comparative study on dopamine turnover in several forebrain structures

4

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Dendritic release of dopamine in the substantia nigra

5

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Monoamine metabolites: their relationship and lack of relationship to monoaminergic neuronal activity.

6

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

In vitro and in vivo release of neurokinin A-like immunoreactivity from rat substantia nigra

7

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Selective agonists for substance P and neurokinin receptors

8

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis

9

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

The substance P(1–7) fragment is a potent modulator of substance P actions in the brain

10

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Effects of haloperidol and clozapine on preprotachykinin-A messenger RNA, tachykinin tissue levels, release and neurokinin-1 receptors in the striato-nigral system

11

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Effects of GABA and L-glutamic acid on the potassium-evoked in vitro release of substance P- and neurokinin A-like immunoreactivities are different in the rat striatum and substantia nigra

12

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Effects of substance P injected into the substantia nigra

13

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Substance P release from the rat substantia nigra.

14

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Neuropeptide-gamma: a peptide isolated from rabbit intestine that is derived from gamma-preprotachykinin

15

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Substance P modulation of dopamine in the nucleus accumbens

16

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Structure and gene organization of bovine neuromedin K precursor

18

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Multiple tachykinin binding sites in peripheral tissues and in brain

20

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Microdialysis combined with a sensitive radioimmunoassay. A technique for studying in vivo release of neuropeptides

21

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

22

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Autoradiographic localization and characterization of tachykinin receptor binding sites in the rat brain and peripheral tissues.

23

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Prediction of peptide retention times in high-pressure liquid chromatography on the basis of amino acid composition

25

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Tissue-specific generation of two preprotachykinin mRNAs from one gene by alternative RNA splicing

26

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Differential modulation of striatal dopamine release by intranigral injection of gamma-aminobutyric acid (GABA), dynorphin A and substance P.

32

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Synthesis and Biological Properties of Enzyme-Resistant Analogues of Substance P

33

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Increased spontaneous activity following substance P infusion into A10 dopaminergic area

34

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Substance P afferents have synaptic contacts with dopaminergic neurons in the ventral tegmental area of the rat.

35

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Intranigral injection of dynorphin in combination with substance P on striatal dopamine metabolism in the rat.

36

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Neuropeptide K: isolation, structure and biological activities of a novel brain tachykinin.

37

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Increased dopamine metabolism in rat striatum after infusions of substance P into the substantia nigra

38

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Topographical distribution of amines and major amine metabolites in the rat striatum.

39

1 reference

10.1016/0014-2999(91)90387-6

https://api.crossref.org/works/10.1016/0014-2999(91)90387-6

5 November 2022

Identifiers

10.1016/0014-2999(91)90387-6

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/1712305

1 reference

Europe PubMed Central

15 February 2018

http://europepmc.org/abstract/MED/1712305

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48768042&oldid=1765352945"